240 related articles for article (PubMed ID: 28955092)
1. Role of 5-ALA in improving extent of tumour resection in patients with Glioblastoma Multiforme.
Waqas M; Khan I; Shamim MS
J Pak Med Assoc; 2017 Oct; 67(10):1630-1632. PubMed ID: 28955092
[TBL] [Abstract][Full Text] [Related]
2. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.
Hauser SB; Kockro RA; Actor B; Sarnthein J; Bernays RL
Neurosurgery; 2016 Apr; 78(4):475-83. PubMed ID: 26407129
[TBL] [Abstract][Full Text] [Related]
3. 5-aminolevulinic acid guidance during awake craniotomy to maximise extent of safe resection of glioblastoma multiforme.
Corns R; Mukherjee S; Johansen A; Sivakumar G
BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26177997
[TBL] [Abstract][Full Text] [Related]
4. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
[TBL] [Abstract][Full Text] [Related]
5. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
6. Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery.
Cordova JS; Gurbani SS; Holder CA; Olson JJ; Schreibmann E; Shi R; Guo Y; Shu HK; Shim H; Hadjipanayis CG
Mol Imaging Biol; 2016 Jun; 18(3):454-62. PubMed ID: 26463215
[TBL] [Abstract][Full Text] [Related]
7. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
[TBL] [Abstract][Full Text] [Related]
8. Combination of 5-ALA and iMRI in re-resection of recurrent glioblastoma.
Quick-Weller J; Lescher S; Forster MT; Konczalla J; Seifert V; Senft C
Br J Neurosurg; 2016 Jun; 30(3):313-7. PubMed ID: 26743016
[TBL] [Abstract][Full Text] [Related]
9. Pathological analysis of the surgical margins of resected glioblastomas excised using photodynamic visualization with both 5-aminolevulinic acid and fluorescein sodium.
Yano H; Nakayama N; Ohe N; Miwa K; Shinoda J; Iwama T
J Neurooncol; 2017 Jun; 133(2):389-397. PubMed ID: 28432590
[TBL] [Abstract][Full Text] [Related]
10. 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma.
Schucht P; Knittel S; Slotboom J; Seidel K; Murek M; Jilch A; Raabe A; Beck J
Acta Neurochir (Wien); 2014 Feb; 156(2):305-12; discussion 312. PubMed ID: 24449075
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence-guided resection of primary and recurrent malignant gliomas with 5-aminolevulinic acid. Preliminary results.
Tykocki T; Michalik R; Bonicki W; Nauman P
Neurol Neurochir Pol; 2012; 46(1):47-51. PubMed ID: 22426762
[TBL] [Abstract][Full Text] [Related]
12. Role of Intra-operative MRI (iMRI) in Improving Extent of Resection and Survival in Patients with Glioblastoma Multiforme.
Khan I; Waqas M; Shamim MS
J Pak Med Assoc; 2017 Jul; 67(7):1121-1123. PubMed ID: 28770902
[TBL] [Abstract][Full Text] [Related]
13. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies.
Colditz MJ; Jeffree RL
J Clin Neurosci; 2012 Nov; 19(11):1471-4. PubMed ID: 22959448
[TBL] [Abstract][Full Text] [Related]
14. 5-ALA fluorescence-assisted surgery in pediatric brain tumors: report of three cases and review of the literature.
Barbagallo GM; Certo F; Heiss K; Albanese V
Br J Neurosurg; 2014 Dec; 28(6):750-4. PubMed ID: 24799277
[TBL] [Abstract][Full Text] [Related]
15. Current surgical management of glioblastoma.
Hentschel SJ; Lang FF
Cancer J; 2003; 9(2):113-25. PubMed ID: 12784877
[TBL] [Abstract][Full Text] [Related]
16. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
Coburger J; Hagel V; Wirtz CR; König R
PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
[TBL] [Abstract][Full Text] [Related]
17. Letter to the Editor. 5-ALA fluorescence-guided surgery as standard of care in the resection of GBM.
Foo JQX; Zheng Y
J Neurosurg; 2024 Feb; 140(6):1816-1817. PubMed ID: 38364225
[No Abstract] [Full Text] [Related]
18. Neurosurgical oncology: advances in operative technologies and adjuncts.
D'Amico RS; Kennedy BC; Bruce JN
J Neurooncol; 2014 Sep; 119(3):451-63. PubMed ID: 24969924
[TBL] [Abstract][Full Text] [Related]
19. [Surgery of high-grade gliomas guided by fluorescence: a retrospective study of 22 patients].
Jacquesson T; Ducray F; Maucort-Boulch D; Armoiry X; Louis-Tisserand G; Mbaye M; Pelissou-Guyotat I; Guyotat J
Neurochirurgie; 2013 Feb; 59(1):9-16. PubMed ID: 23318102
[TBL] [Abstract][Full Text] [Related]
20. Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.
Sage W; Guilfoyle M; Luney C; Young A; Sinha R; Sgubin D; McAbee JH; Ma R; Jefferies S; Jena R; Harris F; Allinson K; Matys T; Qian W; Santarius T; Price S; Watts C
J Neurooncol; 2018 Jan; 136(2):273-280. PubMed ID: 29139095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
